These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 17052260
1. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J, Shiota G. Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260 [Abstract] [Full Text] [Related]
2. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM. Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359 [Abstract] [Full Text] [Related]
3. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Zhu CQ, Cutz JC, Liu N, Lau D, Shepherd FA, Squire JA, Tsao MS. Br J Cancer; 2006 May 22; 94(10):1452-9. PubMed ID: 16641908 [Abstract] [Full Text] [Related]
4. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. Hara H, Yamashita K, Shinada J, Yoshimura H, Kameya T. Lung Cancer; 2001 Nov 22; 34(2):219-26. PubMed ID: 11679180 [Abstract] [Full Text] [Related]
5. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies. Miura N, Kanamori Y, Takahashi M, Sato R, Tsukamoto T, Takahashi S, Harada T, Sano A, Shomori K, Harada T, Kigawa J, Ito H, Terakawa N, Hasegawa J, Shiota G. Oncol Rep; 2007 Mar 22; 17(3):541-8. PubMed ID: 17273731 [Abstract] [Full Text] [Related]
6. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer. Zalewska-Ziob M, Dobija-Kubica K, Biernacki K, Adamek B, Kasperczyk J, Bruliński K, Ostrowska Z. Acta Biochim Pol; 2017 Mar 22; 64(4):641-646. PubMed ID: 29141053 [Abstract] [Full Text] [Related]
8. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients. Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G. Clin Transl Oncol; 2016 Apr 22; 18(4):360-8. PubMed ID: 26307752 [Abstract] [Full Text] [Related]
9. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L, Sun JJ, Cui YC, Jiang SL, Wang XW, Lv LY, Xie L, Song XR. Tumour Biol; 2016 Jul 22; 37(7):9979-87. PubMed ID: 26819207 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. Dziadziuszko R, Merrick DT, Witta SE, Mendoza AD, Szostakiewicz B, Szymanowska A, Rzyman W, Dziadziuszko K, Jassem J, Bunn PA, Varella-Garcia M, Hirsch FR. J Clin Oncol; 2010 May 01; 28(13):2174-80. PubMed ID: 20351332 [Abstract] [Full Text] [Related]
11. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma. Li YR, Wu JM, Wang L, Huang X, Shi J, Hu LH. Acta Otolaryngol; 2005 Apr 01; 125(4):409-14. PubMed ID: 15823813 [Abstract] [Full Text] [Related]
12. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G. Clin Cancer Res; 2005 May 01; 11(9):3205-9. PubMed ID: 15867214 [Abstract] [Full Text] [Related]
13. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance. Wu CH, Lin SR, Hsieh JS, Chen FM, Lu CY, Yu FJ, Cheng TL, Huang TJ, Huang SY, Wang JY. Dis Markers; 2006 May 01; 22(3):103-9. PubMed ID: 16788243 [Abstract] [Full Text] [Related]
14. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases. Warnecke-Eberz U, Bollschweiler E, Drebber U, Pohl A, Baldus SE, Hoelscher AH, Metzger R. Oncol Rep; 2008 Sep 01; 20(3):619-24. PubMed ID: 18695914 [Abstract] [Full Text] [Related]
15. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer. Huang Q, Fan J, Qian X, Lv Z, Zhang X, Han J, Wu F, Chen C, Du J, Guo M, Hu G, Jin Y. J Cancer Res Clin Oncol; 2016 Jan 01; 142(1):263-72. PubMed ID: 26319393 [Abstract] [Full Text] [Related]
16. Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer. Zhang Y, Yang H, Qiu Y, Deng Q, Liu J, Zhao M, He P, Mo M, Zou X, He J. Med Oncol; 2014 Mar 01; 31(3):803. PubMed ID: 24452282 [Abstract] [Full Text] [Related]
17. Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project. Van den Berg RM, Brokx H, Vesin A, Field JK, Brambilla C, Meijer CJ, Sutedja GT, Heideman DA, Postmus PE, Smit EF, Snijders PJ. Int J Oncol; 2010 Aug 01; 37(2):455-61. PubMed ID: 20596673 [Abstract] [Full Text] [Related]
18. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Takanami I. Oncol Rep; 2004 Oct 01; 12(4):849-53. PubMed ID: 15375511 [Abstract] [Full Text] [Related]
19. Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation. Marchetti A, Pellegrini C, Buttitta F, Falleni M, Romagnoli S, Felicioni L, Barassi F, Salvatore S, Chella A, Angeletti CA, Roncalli M, Coggi G, Bosari S. Lab Invest; 2002 Jun 01; 82(6):729-36. PubMed ID: 12065683 [Abstract] [Full Text] [Related]
20. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer. Xing R, Chen KB, Xuan Y, Feng C, Xue M, Zeng YC. Surg Oncol; 2016 Sep 01; 25(3):147-51. PubMed ID: 27566015 [Abstract] [Full Text] [Related] Page: [Next] [New Search]